SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " CVS Health's " 4 found 🔀 AI-powered Shuffle
CVS Health (CVS) Stock Looks Reasonable On Fresh Vaccine Access News
CVS Health, the integrated pharmacy and health services group, has delivered a 35.0% share price gain over the past three years, which puts fresh attention on whether its current US$86.16 price fairly reflects what the business earns today. With the stock giving back some ground in recent weeks, investors are again asking how much of CVS Health's earnings story is already in the quote. The 35.0% return over three years has rewarded patient holders, which raises the question of how much of...
Why Is CVS Health (CVS) Reworking Primary Care Around Value Based Care?
CVS Health (NYSE:CVS) is expanding its primary care approach by integrating value-based care across its health system. The company intends to connect health plans, provider groups, clinics, and pharmacies under a single patient-centered care model. Management is targeting shared accountability for outcomes that include social determinants of health alongside traditional clinical metrics. This push to embed value-based care across CVS Health's operations reshapes how the group manages care,...
CVS Health's Aetna to streamline cancer treatment approvals
CVS Health's Aetna health insurance unit will cut back next year on the preapprovals it requires for treatment for cancer patients to only one medical prior authorization process early on, the company said on Thursday.
CVS Health Corporation (NYSE:CVS) is favoured by institutional owners who hold 88% of the company
Key Insights Significantly high institutional ownership implies CVS Health's stock price is sensitive to their trading...